Safe use of pulse oximetry during verteporphin therapy. Anesth Analg 2003 Jan;96(1):177-8, table of contents
Date
12/31/2002Pubmed ID
12505948DOI
10.1097/00000539-200301000-00037Scopus ID
2-s2.0-0037221698 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
Pulse oximetry may produce skin damage after the administration of photosensitizing chemotherapeutic drugs. Surgery must often be performed in near darkness during photodynamic therapy. Limiting the duration of pulse oximetry and rotating sites allowed successful use of pulse oximetry in a long anesthetic during which verteporphin was administered.
Author List
Woehlck H, Herrmann D, Kaslow OAuthors
Olga Y. Kaslow MD, PhD Professor in the Anesthesiology department at Medical College of WisconsinHarvey J. Woehlck MD Professor in the Anesthesiology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
CyanosisHumans
Male
Meningioma
Middle Aged
Neoplasm Recurrence, Local
Oximetry
Photochemotherapy
Photosensitizing Agents
Porphyrins
Skin Diseases